News

Dr. Anitha Mitchell Logan, an alumna of the College of Natural Sciences, is one of six winners of this year's Distinguished Alumnus Awards from the Texas Exes, the alumni association of the University of Texas at Austin. The awards, currently celebrating their 60^th anniversary, are given annually to alumni who have distinguished themselves professionally and through service to the university.

James P. Allison, a world-renowned pioneer of cancer immunotherapy, has been awarded the 2018 Nobel Prize in physiology or medicine jointly with Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation."

Last year, University of Texas at Austin alumnus Michael Young won the Nobel prize in physiology or medicine for discovering the molecular mechanism behind circadian rhythms. Circadian clocks are critical for the health of all living things, acting as the internal timekeepers in plants and animals that help to synchronize functions like eating and sleeping with our planet's daily rhythm of light and dark.

​Ryan Huizar, a recent UT Austin alum, is embarking on a new journey this fall at Johns Hopkins University School of Medicine at one of the most competitive MD-PhD programs in the nation. The MD-PhD dual doctoral degree prepares students for careers as physician-scientists, balancing research and clinical care of patients.

Sydney Jones (BSA, '10) has studied cardiovascular health and diabetes on the Texas border, researched improvements for stroke care in North Carolina, and promoted community health, working with a nonprofit organization. Now the University of Texas alumna is taking on a new role: disease detective for the Centers for Disease Control and Prevention.

Ewin Tang, a 2018 University of Texas at Austin graduate in computer science and mathematics, is receiving national attention for a feat accomplished at the age of 18 by disproving, as part of an honors thesis, a widely held assumption about the hottest next-thing in technology, quantum computing.

Forty years ago, when James Allison had just gotten his PhD in biochemistry, he was intrigued by this far-out idea that was floating around about a new way to treat cancer. The idea—dubbed cancer immunotherapy—was to train the body's immune system to attack cancer cells—the same way this system already goes after bacteria and viruses. He was one of the few people who actually believed it could work.

​This is the time of year when we in the College of Natural Sciences congratulate and recognize our new graduates. Making it to this point is not an easy feat. As alumni will tell you, it requires years of hard work, meeting aggressive deadlines and learning to thrive in an environment where many different things are coming your way.

André Nahmias (BA '50, MA '52) first encountered what he calls "the ecstasy of discovery" when he was a University of Texas at Austin student. In the intervening decades as an infectious disease research pediatrician, he made a number of discoveries that benefited people with various bacterial and viral infections.

One of the world's leading pediatric heart surgeons, Charles Fraser, Jr., M.D., will join the faculty of the Dell Medical School at The University of Texas at Austin as professor in the Departments of Surgery and Perioperative Care and Pediatrics. He will also serve as chief of pediatric and congenital cardiothoracic surgery at Dell Children's Medical Center of Central Texas.